---
title: "12 Health Care Stocks Moving In Thursday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288776514.md"
description: "In Thursday's after-market session, several healthcare stocks saw significant movement. Gainers included Bio Green Med Solution (+152.8%), Basel Medical Group (+18.55%), and Shuttle Pharmaceuticals (+12.24%). Conversely, losers featured Indaptus Therapeutics (-29.7%), Nyxoah (-22.57%), and BioRestorative Therapies (-10.67%). These fluctuations reflect trading activity in the healthcare sector during extended hours."
datetime: "2026-06-04T21:05:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288776514.md)
  - [en](https://longbridge.com/en/news/288776514.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288776514.md)
---

# 12 Health Care Stocks Moving In Thursday's After-Market Session

### Gainers

-   **Bio Green Med Solution** (NASDAQ:BGMS) shares rose 152.8% to $2.68 during Thursday's after-market session. The market value of their outstanding shares is at $5.8 million.
-   **Basel Medical Group** (NASDAQ:BMGL) shares rose 18.55% to $0.57. The market value of their outstanding shares is at $12.3 million.
-   **Shuttle Pharmaceuticals** (NASDAQ:SHPH) stock rose 12.24% to $0.55. The market value of their outstanding shares is at $3.0 million.
-   **NuCana** (NASDAQ:NCNA) stock rose 11.24% to $2.24. The company's market cap stands at $8.4 million.
-   **ALPS Group** (NASDAQ:ALPS) stock moved upwards by 8.23% to $0.76. The company's market cap stands at $118.1 million.
-   **Codexis** (NASDAQ:CDXS) shares increased by 6.07% to $2.97. The market value of their outstanding shares is at $247.2 million.

### Losers

-   **Indaptus Therapeutics** (NASDAQ:INDP) stock declined by 29.7% to $3.34 during Thursday's after-market session. The market value of their outstanding shares is at $250.2 million.
-   **Nyxoah** (NASDAQ:NYXH) stock fell 22.57% to $2.23. The market value of their outstanding shares is at $128.2 million.
-   **BioRestorative Therapies** (NASDAQ:BRTX) stock declined by 10.67% to $0.37. The market value of their outstanding shares is at $8.6 million.
-   **Picard Medical** (AMEX:PMI) stock decreased by 10.15% to $0.29. The market value of their outstanding shares is at $28.7 million.
-   **Exicure** (NASDAQ:XCUR) shares fell 7.72% to $2.75. The company's market cap stands at $20.1 million. The company's, Q1 earnings came out 4 days ago.
-   **Nexalin Technology** (NASDAQ:NXL) shares declined by 7.38% to $0.5. The market value of their outstanding shares is at $11.4 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [INDP.US](https://longbridge.com/en/quote/INDP.US.md)
- [BGMS.US](https://longbridge.com/en/quote/BGMS.US.md)
- [BMGL.US](https://longbridge.com/en/quote/BMGL.US.md)
- [BRTX.US](https://longbridge.com/en/quote/BRTX.US.md)
- [SHPH.US](https://longbridge.com/en/quote/SHPH.US.md)
- [NYXH.US](https://longbridge.com/en/quote/NYXH.US.md)
- [NCNA.US](https://longbridge.com/en/quote/NCNA.US.md)
- [ALPS.US](https://longbridge.com/en/quote/ALPS.US.md)
- [CDXS.US](https://longbridge.com/en/quote/CDXS.US.md)
- [PMI.US](https://longbridge.com/en/quote/PMI.US.md)
- [XCUR.US](https://longbridge.com/en/quote/XCUR.US.md)
- [NXL.US](https://longbridge.com/en/quote/NXL.US.md)
- [BGMSP.US](https://longbridge.com/en/quote/BGMSP.US.md)
- [ALPWF.US](https://longbridge.com/en/quote/ALPWF.US.md)
- [NXLIW.US](https://longbridge.com/en/quote/NXLIW.US.md)

## Related News & Research

- [BioRestorative Revamps Board Following New Loan Agreement](https://longbridge.com/en/news/289647192.md)
- [Bio Green Med Solution Shares Surge 186% On Business Combination Agreement](https://longbridge.com/en/news/288805175.md)
- [Nyxoah Updates Capital Structure After Major Share Issuance](https://longbridge.com/en/news/289396444.md)
- [As tech stocks slide, the healthcare sector shines. Why some experts say they like this defensive play](https://longbridge.com/en/news/289242691.md)
- [H.C. Wainwright Reaffirms Their Buy Rating on NervGen Pharma (NGEN)](https://longbridge.com/en/news/289477645.md)